Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models
- 8 October 2003
- journal article
- research article
- Published by Wiley in Microsurgery
- Vol. 23 (5) , 454-457
- https://doi.org/10.1002/micr.10171
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cyclosporine withdrawal in stable renal transplant recipients after azathioprine‐mycophenolate mofetil conversionClinical Transplantation, 2000
- MYCOPHENOLATE MOFETIL, AN ALTERNATIVE TO CYCLOSPORINE A FOR LONG-TERM IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION?1,2Transplantation, 2000
- CONVERSION TO MYCOPHENOLATE MOFETIL IN CONJUNCTION WITH STEPWISE WITHDRAWAL OF CYCLOSPORINE IN STABLE RENAL TRANSPLANT RECIPIENTS1Transplantation, 2000
- Mechanisms of chronic rejectionTransplantation Proceedings, 1999
- Chronic rejection: new potential venues of therapyTransplantation Proceedings, 1999
- MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-ASSOCIATED NEPHROTOXICITYTransplantation, 1998
- Immunosuppressive Agents: Recent Developments in Molecular Action and Clinical ApplicationTransplantation Proceedings, 1998
- Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allograftsTransplant Immunology, 1996
- SEQUENTIAL IMMUNOLOGICAL TARGETING OF CHRONIC EXPERIMENTAL ARTERIAL ALLOGRAFTTransplantation, 1995
- Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantationThe Lancet, 1995